ForCast Orthopedics Inc

LONGMONT, CO · Medtech · Private

AI and machine learning software solutions for enterprise clients, including data science, image processing, and blockchain applications

Claim this profile

Follows are private to you and power your alerts

Updated · forcastortho.com

Sector
Medtech
Headquarters
LONGMONT, CO
Latest Form D
$3.8M, Aug 2025
Total capital
$5.2M
Federal grants
$1.4M
2 awards · 2019–2020
Rank in peer group#304 of 477
Private capital raised
$3.8M
1 Form D · last Aug 2025
14 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
11 pending · first 2019
Rank in peer group#99 of 477

Capital timeline

2019202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $5.2M$225K$1.2M1st Form D$3.8M
2019202120232025FEDERAL ↑EQUITY ↓Cumulative $5.2M$225K$1.2M1st Form D$3.8M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$3.8M
  • Federal grantNSF · Phase II · SBIR Phase II: Antibiotic-Dispensing Spacer for Improved Periprosthetic Joint Infection (PJI) Treatment$1.2M
  • Federal grantNSF · Phase I · SBIR Phase I: Antibiotic Dispensing Spacer for improved treatment of PJI in TKA$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

78months

from ForCast Orthopedics Inc’s first federal award to its first private round.

First federal award · Feb 2019
NSF · $225K
First Form D · Aug 2025
$3.8M · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#99 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Charles DeCookDirectorNamed in SEC Form D filings
  • Jared ForanExecutive Officer, DirectorNamed in SEC Form D filings
  • Peter NoymerExecutive Officer, DirectorNamed in SEC Form D filings
  • Terry OpgenorthDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 14
Show all 14 patent records
  • Method System And Apparatus For Drug Delivery And TreatmentJun 4, 2026 · Application 19457387Pending
  • Implantable Externally Driven Fluid Delivery SystemAug 22, 2023 · US 11,730,884Granted
  • Method, System, And Apparatus For Antibiotic Dispensing Knee ProsthesisMar 15, 2022 · US 11,273,044Granted
  • Prosthetic Knee Spacer And Method Of Using The SameDec 16, 2021 · Application 17284868Pending
  • Antibiotic Dispensing Spacer Apparatus And Method For Infected Total Knee ArthroplastyApr 23, 2019 · US 10,265,182Granted
  • Wearable Pump SystemApplication 63493339Pending
  • Catheter For Wearable Medical DeviceApplication 63493344Pending
  • Implantable Externally Driven Fluid Delivery SystemApplication PCTUS2021046221Pending
  • Method System And Apparatus For Drug Delivery And TreatmentApplication 63515599Pending
  • Wearable Medical DeviceApplication PCTUS2024022273Pending
  • Method System And Apparatus For Drug Delivery And TreatmentApplication PCTUS2024039519Pending
  • Prosthetic Knee Spacer And Method Of Using The SameApplication PCTUS2019059365Pending
  • Implantable Externally Driven Fluid Delivery SystemApplication 62896152Pending
  • Wearable Medical DeviceApplication 19471094Pending
  • NeuroPrex Inc.Similar federal contract value in Medtech · null in contracts
  • EMANATE WIRELESS, INC.Similar federal contract value in Medtech · null in contracts
  • AIRITY TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
  • SENTIRE MEDICAL SYSTEMS, INC.Similar federal contract value in Medtech · null in contracts
  • RESELUTE, INC.Similar federal contract value in Medtech · null in contracts
  • ORALIVA, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .